384 related articles for article (PubMed ID: 1703037)
1. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
[TBL] [Abstract][Full Text] [Related]
2. Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis.
Prasanna P; Shack S; Wilson VL; Samid D
Clin Cancer Res; 1995 Aug; 1(8):865-71. PubMed ID: 9816056
[TBL] [Abstract][Full Text] [Related]
3. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
Tuck AB; Wilson SM; Chambers AF
Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
[TBL] [Abstract][Full Text] [Related]
4. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
7. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
Endlich B; Salavati R; Sullivan T; Ling CC
Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
[TBL] [Abstract][Full Text] [Related]
8. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
Samid D; Miller AC; Rimoldi D; Gafner J; Clark EP
Radiat Res; 1991 May; 126(2):244-50. PubMed ID: 2023995
[TBL] [Abstract][Full Text] [Related]
9. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
Kogerman P; Sy MS; Culp LA
Oncogene; 1997 Sep; 15(12):1407-16. PubMed ID: 9333016
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the human Harvey-ras oncogene expression by DNA methylation.
Borrello MG; Pierotti MA; Donghi R; Bongarzone I; Cattadori MR; Traversari C; Mondellini P; Della Porta G
Oncogene Res; 1988; 2(2):197-203. PubMed ID: 2464152
[TBL] [Abstract][Full Text] [Related]
11. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
Wang Y; Iliakis G
Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
[TBL] [Abstract][Full Text] [Related]
12. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
[TBL] [Abstract][Full Text] [Related]
13. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
14. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
15. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
Garbisa S; Pozzatti R; Muschel RJ; Saffiotti U; Ballin M; Goldfarb RH; Khoury G; Liotta LA
Cancer Res; 1987 Mar; 47(6):1523-8. PubMed ID: 3028610
[TBL] [Abstract][Full Text] [Related]
16. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
18. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.
Samid D; Flessate DM; Friedman RM
Mol Cell Biol; 1987 Jun; 7(6):2196-200. PubMed ID: 2439904
[TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
